germinal testicular tumorsrecurrenceschemotherapypredictorsгерминогенная опухольрецидивыхимиотерапияфакторы прогноза1.1. Трякин А.А., Буланов А.А.,Тюляндин С.А. Индукционная химиоте-рапия метастатических герминогенных опухолей. Практ онкол 2006;7(1):30-8.Трякин А.А., Буланов А.А.,Тюляндин С.А. Индукционная химиоте-рапия метастатических герминогенных опухолей. Практ онкол 2006;7(1):30-8.2.2. Тюляндин С.А. Лечение диссеминиро-ванных герминогенных опухолей у муж-чин. В сб.: Материалы VI Российской он-кологической конференции 26-28 ноя-бря 2002 г. М., 2002.Тюляндин С.А. Лечение диссеминиро-ванных герминогенных опухолей у муж-чин. В сб.: Материалы VI Российской он-кологической конференции 26-28 ноя-бря 2002 г. М., 2002.3.3. Motzer R.J., Sheinfeld J., Mazumdar M. et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000;18(12):2413-8.Motzer R.J., Sheinfeld J., Mazumdar M. et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000;18(12):2413-8.4.4. Bhatia S., Abomow R., Porcu P. et al. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 2000;18:3346-51.Bhatia S., Abomow R., Porcu P. et al. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 2000;18:3346-51.5.5. Broun E.R., Nichols C.R., Kneebone P. et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992;117(2):124-8.Broun E.R., Nichols C.R., Kneebone P. et al. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992;117(2):124-8.6.6. Siegert W., Beyer J., Strohscheer I. et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 1994;12(6):1223-31.Siegert W., Beyer J., Strohscheer I. et al. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 1994;12(6):1223-31.7.7. Kondagunta G., Bacik J., Sheinfeld J. et al. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 2007;25:85-90.Kondagunta G., Bacik J., Sheinfeld J. et al. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors. J Clin Oncol 2007;25:85-90.8.8. Loehrer P.J., Gonin R., Nichols C.R. et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998;16:2500-4.Loehrer P.J., Gonin R., Nichols C.R. et al. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 1998;16:2500-4.9.9. Fossa S.D., Stenning S.P., Gerl A. et al. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 1999;80(9):1392-9.Fossa S.D., Stenning S.P., Gerl A. et al. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer 1999;80(9):1392-9.10.10. Beyer J., Kramar A., Mandanas R. et al. High-dose chemotherapy as salvage treatment in germ cell tumors. A multivariate analysis of prognostic variables. J Clin Oncol 1996;14:2638-45.Beyer J., Kramar A., Mandanas R. et al. High-dose chemotherapy as salvage treatment in germ cell tumors. A multivariate analysis of prognostic variables. J Clin Oncol 1996;14:2638-45.11.11. Vaena D.A., Abonour R., Einhorn L.H. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. Proc Am Soc Clin Oncol 2003. Abstr 1538.Vaena D.A., Abonour R., Einhorn L.H. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. Proc Am Soc Clin Oncol 2003. Abstr 1538.